Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Supernus Pharmaceuticals (NASDAQ:SUPN) through any online brokerage.
Other companies in Supernus Pharmaceuticals’s space includes: Atai Beckley NV (NASDAQ:ATAI), WAVE Life Sciences Ltd (NASDAQ:WVE), Tarsus Pharmaceuticals Inc (NASDAQ:TARS), Phibro Animal Health Corp (NASDAQ:PAHC) and Terns Pharmaceuticals Inc (NASDAQ:TERN).
Supernus Pharmaceuticals has a consensus price target of $63.25.
The stock price for Supernus Pharmaceuticals (NASDAQ: SUPN) is $47.16 last updated December 12, 2025 at 4:00 PM EST.
There are no upcoming dividends for Supernus Pharmaceuticals.
Supernus Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Supernus Pharmaceuticals.
Supernus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.